Loading clinical trials...

Metabiomics Colon Cancer Clinical Research Study | Clinical Trials | Clareo Health

WITHDRAWN

Metabiomics Colon Cancer Clinical Research Study

NCT02151123•Metabiomics Corp

Summary

The specific aim of the study is to determine the false negative rate of the Metabiomics Colon Polyp and Colorectal Cancer Assay for Cancer.

Detailed Description

The purpose of this study is to conduct clinical research to investigate the association of the gut microbiome with colonic neoplasia. In this case several types of gut microbiome samples will be collected from patients undergoing colectomy for colonic adenocarcinoma; those samples will be tested by Metabiomics Colon Polyp and Colorectal Cancer Assay and the percentage of false negative (test returns a negative for cancer) results determined.

Eligibility

Age

18 - 95 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Recently diagnosed with colorectal cancer (CRC) and scheduled for colectomy
•Male or female,
•Age: 18-95 years,
•Able to comprehend, sign, and date the written informed consent form (ICF),
•Able to give informed consent in English
•Women and minorities will be included.

Exclusion Criteria

•History of Inflammatory Bowel Disease
•Antibiotics within 2 weeks of sample collection.
•Colonoscopy, colon prep or bowel contrast agent within 7 days prior to sample collection
•Any radiation therapy

Locations (1)

University of Colorado School of Medicine Anschutz Medical Campus

Aurora, Colorado, United States

Key Dates

Start Date

March 1, 2019

Primary Completion Date

March 1, 2020

Completion Date

September 1, 2020

Last Updated

September 26, 2025

Conditions

Colonic Neoplasms

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

NCT06885697

MesotheliomaNeoplasms+6 more

View study

RECRUITINGNA

Effects of Aerobic Exercise on Skeletal Muscle Remodeling in Colorectal Cancer

NCT05789433

Colonic NeoplasmsRectal Neoplasms

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 26, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Metabiomics Colon Cancer Clinical Research Study

Inclusion Criteria

Exclusion Criteria

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

Effects of Aerobic Exercise on Skeletal Muscle Remodeling in Colorectal Cancer

Local Cecal Cancer - Optimization of Surgical Treatment

Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers

Artificial Intelligence for Leaving in Situ Colorectal Polyps.

Efficacy and Safety of a Solution for Endoscopic Mucosal Resection of Colonic Lesions